ID   STR-I-209-MEN2a
AC   CVCL_C086
SY   STR-209-MEN2a; INSERMe006-A; INSRMe006-A
DR   hPSCreg; INSRMe006-A
DR   ISCR; 1265
DR   SKIP; SKIP002320
DR   Wikidata; Q54970612
RX   PubMed=20217271;
WW   https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_209_men2a.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-075-L1.
CC   Sequence variation: Mutation; HGNC; 9967; RET; Simple; p.Cys634Arg (c.1900T>C); ClinVar=VCV000013917; Zygosity=Unspecified (PubMed=20217271).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3226; Multiple endocrine neoplasia type 2A
DI   ORDO; Orphanet_247698; Multiple endocrine neoplasia type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 16
//
RX   PubMed=20217271; DOI=10.1007/s11626-010-9300-8;
RA   Tropel P., Tournois J., Come J., Varela C., Moutou C., Fragner P.,
RA   Cailleret M., Laabi Y., Peschanski M., Viville S.;
RT   "High-efficiency derivation of human embryonic stem cell lines
RT   following pre-implantation genetic diagnosis.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:376-385(2010).
//